Your browser doesn't support javascript.
loading
A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Primary analysis.
Ishikawa, Mitsuya; Shibata, Taro; Iwata, Takashi; Nishio, Shin; Takada, Toshio; Suzuki, Shiro; Horie, Koji; Kudaka, Wataru; Kagabu, Masahiro; Tanikawa, Michihiro; Kitagawa, Ryo; Takekuma, Munetaka; Kobayashi, Hiroaki; Yaegashi, Nobuo.
Afiliación
  • Ishikawa M; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: miishika@ncc.go.jp.
  • Shibata T; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Iwata T; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
  • Nishio S; Department of Obstetrics and Gynecology, Kurume University School of Medicine, Fukuoka, Japan.
  • Takada T; Department of Obstetrics and Gynecology, Kitasato University School of Medicine, Kanagawa, Japan.
  • Suzuki S; Department of Gynecologic Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
  • Horie K; Department of Gynecology, Saitama Cancer Center, Saitama, Japan.
  • Kudaka W; Department of Obstetrics and Gynecology, Graduate School of Medical Science, University of the Ryukyus, Okinawa, Japan.
  • Kagabu M; Department of Obstetrics and Gynecology, Iwate Medical University school of Medicine, Iwate, Japan.
  • Tanikawa M; Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kitagawa R; Department of Gynecology and Obstetrics, Moriya Daiichi General Hospital, Ibaraki, Japan.
  • Takekuma M; Division of Gynecology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Kobayashi H; Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.
  • Yaegashi N; Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Gynecol Oncol ; 162(2): 292-298, 2021 08.
Article en En | MEDLINE | ID: mdl-34016453
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Cuello Uterino / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Cuello Uterino / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos